PE20011310A1 - Alquinil fenil amidas heteroaromaticas como activadores de la glucokinasa - Google Patents

Alquinil fenil amidas heteroaromaticas como activadores de la glucokinasa

Info

Publication number
PE20011310A1
PE20011310A1 PE2001000383A PE2001000383A PE20011310A1 PE 20011310 A1 PE20011310 A1 PE 20011310A1 PE 2001000383 A PE2001000383 A PE 2001000383A PE 2001000383 A PE2001000383 A PE 2001000383A PE 20011310 A1 PE20011310 A1 PE 20011310A1
Authority
PE
Peru
Prior art keywords
alkyl
phenyl
alkinyl
glucokinase
heteroaromaticas
Prior art date
Application number
PE2001000383A
Other languages
English (en)
Inventor
Paige Erin Mahaney
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of PE20011310A1 publication Critical patent/PE20011310A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/88—Nitrogen atoms, e.g. allantoin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Abstract

SE REFIERE A COMPUESTOS ALQUINIL FENIL AMIDAS HETEROAROMATICAS DE FORMULA I DONDE R ES H, ALQUILO, OH-ALQUILO, ALCOXILO-ALQUILO, (R1-)(R2-)N(CH2)n-, CICLOALQUILO C5-C6, ENTRE OTROS; R3 ES CICLOALQUILO C3-C7; R4 ES UN ANILLO HETEROAROMATICO DE 5-6 MIEMBROS, (CH2)mOR6, (CH2)mCOOR7, ENTRE OTROS; n ES 1-2; m ES 0-4; R1, R2, R6, R7, R8 SON H, ALQUILO; R1 Y R2 JUNTO A N FORMAN UN ANILLO HETEROAROMATICO DE 5-6 MIEMBROS. SON COMPUESTOS PREFERIDOS 3-CICLOPENTIL-2-(4-ETINIL-FENIL)-N-TIAZOL-2-IL-PROPIONAMIDA, 3-CICLOPENTIL-2-[4-(3-METOXI-PROP-1-INIL)FENIL]-N-TIAZOL-2IL-PROPIONAMIDA, ENTRE OTROS. TAMBIEN SE REFIERE A UN PROCEDIMIENTO PARA LA PREPARACION. EL COMPUESTO I ES ACTIVADOR DE GLUCOQUINASA AUMENTANDO LA SECRECION DE INSULINA Y PUEDE SER UTIL PARA EL TRATAMIENTO DE DIABETES TIPO II
PE2001000383A 2000-05-03 2001-04-27 Alquinil fenil amidas heteroaromaticas como activadores de la glucokinasa PE20011310A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US20154600P 2000-05-03 2000-05-03

Publications (1)

Publication Number Publication Date
PE20011310A1 true PE20011310A1 (es) 2001-12-31

Family

ID=22746271

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2001000383A PE20011310A1 (es) 2000-05-03 2001-04-27 Alquinil fenil amidas heteroaromaticas como activadores de la glucokinasa

Country Status (18)

Country Link
US (1) US6388071B2 (es)
EP (1) EP1282612B1 (es)
JP (1) JP3788935B2 (es)
KR (1) KR100502033B1 (es)
CN (1) CN1176915C (es)
AR (1) AR032453A1 (es)
AT (1) ATE286036T1 (es)
AU (2) AU7049401A (es)
BR (1) BR0110573A (es)
CA (1) CA2407416C (es)
DE (1) DE60108108T2 (es)
EC (1) ECSP014054A (es)
ES (1) ES2233660T3 (es)
MX (1) MXPA02010745A (es)
PE (1) PE20011310A1 (es)
PT (1) PT1282612E (es)
WO (1) WO2001083465A2 (es)
ZA (1) ZA200208542B (es)

Families Citing this family (73)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE0102300D0 (sv) * 2001-06-26 2001-06-26 Astrazeneca Ab Compounds
SE0102299D0 (sv) 2001-06-26 2001-06-26 Astrazeneca Ab Compounds
SE0102764D0 (sv) * 2001-08-17 2001-08-17 Astrazeneca Ab Compounds
EP1336607A1 (en) * 2002-02-19 2003-08-20 Novo Nordisk A/S Amide derivatives as glucokinase activators
US6911545B2 (en) 2001-12-19 2005-06-28 Hoffman-La Roche Inc. Crystals of glucokinase and methods of growing them
GB2409678B (en) * 2001-12-19 2005-09-21 Hoffmann La Roche Crystals of glucokinase and methods of growing them and ligands of glucokinase
HUP0402309A3 (en) * 2001-12-21 2008-09-29 Novo Nordisk As Amide derivatives as glucokinase activators and pharmaceutical compositions containing them
RU2340605C2 (ru) 2002-06-27 2008-12-10 Ново Нордиск А/С Арилкарбонильные производные в качестве терапевтических средств
PL215132B1 (pl) 2002-06-27 2013-10-31 Novo Nordisk As Pochodna arylokarbonylowa jako srodek terapeutyczny, jej zastosowanie i kompozycja farmaceutyczna ja zawierajaca
BR0314864A (pt) * 2002-10-03 2005-08-02 Novartis Ag Compostos orgânicos
GB0226930D0 (en) 2002-11-19 2002-12-24 Astrazeneca Ab Chemical compounds
GB0226931D0 (en) 2002-11-19 2002-12-24 Astrazeneca Ab Chemical compounds
US7132425B2 (en) 2002-12-12 2006-11-07 Hoffmann-La Roche Inc. 5-substituted-six-membered heteroaromatic glucokinase activators
DE60336850D1 (en) * 2003-01-06 2011-06-01 Lilly Co Eli Substituierte arylcyclopropylacetamide als glucokinaseaktivatoren
PL378117A1 (pl) * 2003-02-11 2006-03-06 Prosidion Limited Tricyklopodstawione związki amidowe
ES2399052T3 (es) 2004-01-06 2013-03-25 Novo Nordisk A/S Heteroaril-ureas y su uso como activadores de glucocinasa
BRPI0507734A (pt) * 2004-02-18 2007-07-10 Astrazeneca Ab composto ou um sal, pró-droga ou solvato do mesmo, método de tratar doenças mediadas por glk, e, processo para a preparação de um composto
ES2322709T3 (es) * 2004-02-18 2009-06-25 Astrazeneca Ab Derivados de benzamida y su uso como agentes activadores de la glucocinasa.
BRPI0509573A (pt) 2004-04-02 2007-09-25 Novartis Ag derivados de sulfonamida-tiazolpiridina como ativadores de glicocinase úteis para o tratamento de diabetes do tipo 2
MXPA06011365A (es) 2004-04-02 2006-12-15 Novartis Ag Derivados de tiazolo-piridina, composiciones farmaceuticas que los contienen, y metodos para el tratamiento de condiciones mediadas por glucoquinasa.
TW200600086A (en) * 2004-06-05 2006-01-01 Astrazeneca Ab Chemical compound
BRPI0516595A (pt) 2004-10-16 2008-09-23 Astrazeneca Ab processo para fabricar um composto, e, composto
GB0423043D0 (en) * 2004-10-16 2004-11-17 Astrazeneca Ab Compounds
GB0423044D0 (en) * 2004-10-16 2004-11-17 Astrazeneca Ab Compounds
MX2007006420A (es) * 2004-12-03 2007-07-19 Novo Nordisk As Activadores heteroaromaticos de glucocinasa.
JP2008542247A (ja) * 2005-05-24 2008-11-27 アストラゼネカ アクチボラグ グルコキナーゼモジュレーターとしての２−フェニル置換イミダゾール［４，５ｂ］ピリジン／ピラジンおよびプリン誘導体
TW200714597A (en) * 2005-05-27 2007-04-16 Astrazeneca Ab Chemical compounds
WO2007006760A1 (en) 2005-07-08 2007-01-18 Novo Nordisk A/S Dicycloalkyl urea glucokinase activators
EP2027113A1 (en) * 2005-07-09 2009-02-25 AstraZeneca AB Heteroaryl benzamide derivatives for use as glk activators in the treatment of diabetes
US7642259B2 (en) * 2005-07-09 2010-01-05 Astrazeneca Ab Heteroaryl benzamide derivatives for use as GLK activators in the treatment of diabetes
EP1910350A1 (en) * 2005-07-09 2008-04-16 AstraZeneca AB 2 -heterocyclyloxybenzoyl amino heterocyclyl compounds as modulators of glucokinase for the treatment of type 2 diabetes
WO2007015805A1 (en) 2005-07-20 2007-02-08 Eli Lilly And Company 1-amino linked compounds
US9202182B2 (en) * 2005-08-11 2015-12-01 International Business Machines Corporation Method and system for analyzing business architecture
US20090281142A1 (en) 2005-08-31 2009-11-12 Astellas Pharma Inc. Thiazole derivative
JP2007063225A (ja) 2005-09-01 2007-03-15 Takeda Chem Ind Ltd イミダゾピリジン化合物
WO2007039177A2 (en) 2005-09-29 2007-04-12 Sanofi-Aventis Phenyl- and pyridinyl- 1, 2 , 4 - oxadiazolone derivatives, processes for their preparation and their use as pharmaceuticals
GT200600429A (es) 2005-09-30 2007-04-30 Compuestos organicos
GT200600428A (es) 2005-09-30 2007-05-21 Compuestos organicos
EP1948644A1 (en) * 2005-11-03 2008-07-30 Prosidion Limited Tricyclo substituted amides
PT1951658E (pt) 2005-11-17 2012-11-12 Lilly Co Eli Antagonistas do receptor do glucagon, preparação e utilizações terapêuticas
JP2009515997A (ja) * 2005-11-18 2009-04-16 タケダ サン ディエゴ インコーポレイテッド グルコキナーゼ活性剤
TW200738621A (en) * 2005-11-28 2007-10-16 Astrazeneca Ab Chemical process
US8034822B2 (en) 2006-03-08 2011-10-11 Takeda San Diego, Inc. Glucokinase activators
US8211925B2 (en) 2006-04-28 2012-07-03 Transtech Pharma, Inc. Benzamide glucokinase activators
PE20080251A1 (es) 2006-05-04 2008-04-25 Boehringer Ingelheim Int Usos de inhibidores de dpp iv
EP2049518B1 (en) 2006-05-31 2011-08-31 Takeda San Diego, Inc. Indazole and isoindole derivatives as glucokinase activating agents.
BRPI0715531A2 (pt) 2006-07-24 2014-06-24 Hoffmann La Roche Composto, composição farmacêutica, método para o tratamento de uma enfermidade e/ou distúrbio metabólico, processo para a preparação de compostos e uso do composto
TW200825063A (en) * 2006-10-23 2008-06-16 Astrazeneca Ab Chemical compounds
TW200825060A (en) * 2006-10-26 2008-06-16 Astrazeneca Ab Chemical compounds
WO2008079787A2 (en) 2006-12-20 2008-07-03 Takeda San Diego, Inc. Glucokinase activators
CA2671535A1 (en) * 2006-12-21 2008-06-26 Astrazeneca Ab Novel crystalline compound useful as glk activator
TW200831081A (en) 2006-12-25 2008-08-01 Kyorin Seiyaku Kk Glucokinase activator
CN101622231B (zh) 2007-02-28 2013-12-04 艾德维纳斯医疗私人有限公司 作为葡糖激酶激活剂的2，2，2-三取代的乙酰胺衍生物、它们的制造方法和药学应用
TW200902489A (en) * 2007-03-07 2009-01-16 Kyorin Seiyaku Kk Glucokinase-activating substance
US8173645B2 (en) 2007-03-21 2012-05-08 Takeda San Diego, Inc. Glucokinase activators
CL2009000004A1 (es) * 2008-01-15 2010-02-19 Lilly Co Eli Forma cristalina de r-2-(4-ciclopropansulfonil-fenil)-n-pirazin-2-il-3-(tetrahidropiran-4-il)-propionamida; composicion farmaceutica que comprende a dicha forma cristalina; y uso para el tratamiento de diabetes o hiperglicemia.
CN101918363B (zh) 2008-01-18 2012-09-05 安斯泰来制药株式会社 苯乙酰胺衍生物
US7741327B2 (en) 2008-04-16 2010-06-22 Hoffmann-La Roche Inc. Pyrrolidinone glucokinase activators
US8258134B2 (en) 2008-04-16 2012-09-04 Hoffmann-La Roche Inc. Pyridazinone glucokinase activators
AU2009241137B2 (en) 2008-04-28 2013-10-03 Kyorin Pharmaceutical Co., Ltd. Cyclopentylacrylic acid amide derivative
KR20110052676A (ko) 2008-08-04 2011-05-18 아스트라제네카 아베 피라졸로[3,4]피리미딘-4-일 유도체 및 당뇨병 및 비만을 치료하기 위한 이의 용도
UA104742C2 (uk) 2008-12-19 2014-03-11 Эли Лилли Энд Компани Похідні арилциклопропілацетаміду, застосовні як активатори глюкокінази
GB0902406D0 (en) * 2009-02-13 2009-04-01 Astrazeneca Ab Crystalline polymorphic form
GB0902434D0 (en) * 2009-02-13 2009-04-01 Astrazeneca Ab Chemical process
AR076221A1 (es) * 2009-04-09 2011-05-26 Astrazeneca Ab Derivado de pirazol [4,5-e] pirimidina y su uso para tratar diabetes y obesidad
AR076220A1 (es) 2009-04-09 2011-05-26 Astrazeneca Ab Derivados de pirazol [4,5 - e] pirimidina
US8222416B2 (en) 2009-12-14 2012-07-17 Hoffmann-La Roche Inc. Azaindole glucokinase activators
ES2624780T3 (es) 2010-03-31 2017-07-17 The Scripps Research Institute Reprogramación de células
US8877754B2 (en) * 2010-09-06 2014-11-04 Boehringer Ingelheim International Gmbh Compounds, pharmaceutical compositions and uses thereof
WO2014035872A1 (en) * 2012-08-27 2014-03-06 Amgen Inc. Tricyclic alkynes that interact with glucokinase regulatory protein
EP2878339A1 (en) 2013-12-02 2015-06-03 Siena Biotech S.p.A. SIP3 antagonists
EP3053834B1 (en) 2015-02-04 2019-03-27 Tetra Laval Holdings & Finance S.A. Forming assembly and method for forming a plurality of sealed packs for pourable food products starting from a tube of packaging material
EP3806852A1 (en) 2018-06-12 2021-04-21 vTv Therapeutics LLC Therapeutic uses of glucokinase activators in combination with insulin or insulin analogs

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61115054A (ja) * 1984-11-08 1986-06-02 Taisho Pharmaceut Co Ltd スチレンアルカン酸誘導体
AU6110496A (en) * 1995-06-07 1996-12-30 Sugen, Inc. Phosphatase inhibitors
DK0994108T3 (da) * 1997-06-24 2003-08-18 Zeria Pharm Co Ltd Fremgangsmåde til fremstilling af 2-hydroxybenzamidderivater

Also Published As

Publication number Publication date
DE60108108D1 (de) 2005-02-03
US6388071B2 (en) 2002-05-14
AU7049401A (en) 2001-11-12
CA2407416A1 (en) 2001-11-08
JP2003531898A (ja) 2003-10-28
MXPA02010745A (es) 2003-03-10
CA2407416C (en) 2006-07-18
JP3788935B2 (ja) 2006-06-21
AR032453A1 (es) 2003-11-12
BR0110573A (pt) 2003-04-01
AU2001270494B2 (en) 2005-11-10
CN1176915C (zh) 2004-11-24
KR100502033B1 (ko) 2005-07-25
EP1282612B1 (en) 2004-12-29
ES2233660T3 (es) 2005-06-16
WO2001083465A3 (en) 2002-05-16
EP1282612A2 (en) 2003-02-12
DE60108108T2 (de) 2005-12-08
KR20020093117A (ko) 2002-12-12
US20010053851A1 (en) 2001-12-20
PT1282612E (pt) 2005-04-29
WO2001083465A2 (en) 2001-11-08
ZA200208542B (en) 2004-01-22
CN1432004A (zh) 2003-07-23
ECSP014054A (es) 2002-01-25
ATE286036T1 (de) 2005-01-15

Similar Documents

Publication Publication Date Title
PE20011310A1 (es) Alquinil fenil amidas heteroaromaticas como activadores de la glucokinasa
PE20020049A1 (es) Fenilamidas para amina sustituidas como activadores de glucoquinasa
PE20020056A1 (es) Fenil amidas para-aril o heteroaril sustituidas como activadores de la glucoquinasa
PE20020386A1 (es) Derivados de tetrazolil-fenil acetamida como activadores de glucoquinasa
PE20050090A1 (es) Indol-3-carboxamidas como activadores de glocoquinasa
PE20020335A1 (es) Acetamida de benceno de alfa-acil- y alfa-heteroatomo-sustituido como activadores de la glucoquinasa
PE20011313A1 (es) Activadores de glucoquinasa que contienen hidantoina
RU2363700C2 (ru) Производные хинуклидина и фармацевтические композиции, содержащие их
PE20080906A1 (es) Derivados heteroarilo como inhibidores de citocina
TR200102805T2 (tr) Glikokinaz aktivatörleri
PE20121010A1 (es) Derivados de bencimidazol
PE20091842A1 (es) Pirrolidinonas como activadores de glucoquinasa
TW200639171A (en) Heterocyclic substituted phenyl methanones
PE20020593A1 (es) Activadores de glucocinasa del tipo isoindolin-2-ona
PE20030762A1 (es) Compuestos heterociclicos como antagonistas nk1
PE20051159A1 (es) Derivados de heteroarilaminopirazol como estimulantes de la produccion de insulina
PE20010741A1 (es) Derivados de piperazina como antagonistas de taquicininas
PE20011022A1 (es) Compuestos trans olefinicos activadores glucoquinasa
PE20040772A1 (es) Composicion y actividad antiviral de derivados de piperazina azaindoloxoaceticos
ES2174757B1 (es) Empleo de derivados de firazolinas en la elaboracion de un medicamentopara la prevencion y/o el tratamiento de enfermedades proliferativas celulares.
PE20090601A1 (es) Derivados de piridin-il-oxi-piridinas como inhibidores de alk5
HRP20070286T3 (en) Substituted diketopiperazines and their use as oxytocyn antagonists
PE20061144A1 (es) DERIVADOS DE PIRROLIDINA Y PIPERIDINA ACETILENO COMO ANTAGONISTAS DE LOS RECEPTORES DE GLUTAMATO METABOTROPICO (mGluRs)
PE20080345A1 (es) Derivados de piperazina como agonistas del receptor de gpr38
AR068538A1 (es) Compuesto heterociclico de 5 miembros con actividad supresora de la secrecion de acido

Legal Events

Date Code Title Description
FA Abandonment or withdrawal